BIOMARIN PHARMACEUTICAL INC 8-K

What Happened

• On May 4, 2026, BioMarin Pharmaceutical Inc. (BMRN) announced its financial results for the first quarter ended March 31, 2026. The company furnished a press release as Exhibit 99.1 to a Form 8-K reporting its quarterly results and financial condition.

Key Details

• Date of announcement: May 4, 2026.
• Period covered: Quarter ended March 31, 2026.
• The press release is attached to the 8-K as Exhibit 99.1 (the company furnished — not “filed” — the information under the Exchange Act).
• Cover page Inline XBRL tags are included (interactive data).

Why It Matters

• This 8-K notifies investors that BioMarin has released its Q1 2026 earnings and related financial results; investors should review the attached press release (Exhibit 99.1) for revenue, earnings, guidance, and product-specific details. The filing’s legal notice clarifies the press release is furnished (not filed), which affects incorporation and certain liability provisions under the securities laws.